These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16880076)

  • 1. HIV-related liver disease: infections versus drugs.
    Sidiq H; Ankoma-Sey V
    Gastroenterol Clin North Am; 2006 Jun; 35(2):487-505. PubMed ID: 16880076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of chronic hepatitis B and C in HIV-coinfected patients.
    Soriano V; Barreiro P; Nuñez M
    J Antimicrob Chemother; 2006 May; 57(5):815-8. PubMed ID: 16556638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunistic infections update.
    Proj Inf Perspect; 1998 Dec; (26):5-6. PubMed ID: 11366497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral hepatitis and HIV coinfection.
    Sulkowski MS
    J Hepatol; 2008 Feb; 48(2):353-67. PubMed ID: 18155314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
    Macías J; Mira JA; López-Cortés LF; Santos I; Girón-González JA; González-Serrano M; Merino D; Hernández-Quero J; Rivero A; Merchante N; Trastoy M; Carrillo-Gómez R; Arizcorreta-Yarza A; Gómez-Mateos J; Pineda JA
    Antivir Ther; 2006; 11(7):839-46. PubMed ID: 17302246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study.
    Bellini C; Keiser O; Chave JP; Evison J; Fehr J; Kaiser L; Weber R; Vernazza P; Bernasconi E; Telenti A; Cavassini M;
    HIV Med; 2009 Jan; 10(1):12-8. PubMed ID: 18795964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
    Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
    HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Halota W; Pawłowska M
    Przegl Epidemiol; 2002; 56 Suppl 5():41-5. PubMed ID: 15553071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy?
    Jain MK; Opio CK; Osuagwu CC; Pillai R; Keiser P; Lee WM
    Clin Infect Dis; 2007 Apr; 44(7):996-1000. PubMed ID: 17342656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/HCV co-infection: histopathologic findings, natural history, fibrosis, and impact of antiretroviral treatment: a review article.
    Petrovic LM
    Liver Int; 2007 Jun; 27(5):598-606. PubMed ID: 17498243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
    Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
    AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment of HIV/hepatitis B virus coinfection.
    Iser DM; Sasadeusz JJ
    J Gastroenterol Hepatol; 2008 May; 23(5):699-706. PubMed ID: 18410604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hepatitis B virus in HIV-positive patients.
    Shire NJ; Sherman KE
    Minerva Gastroenterol Dietol; 2006 Mar; 52(1):67-87. PubMed ID: 16554708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
    Cooper CL; Mills E
    Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.